November/December 2022 | Medical Editors' Page
Proceed with Caution
Allen C. Ho, MD, and Robert L. Avery, MD
November/December 2022 | Meeting Minutes
ARDS 2022: The Panels
Experts discussed advances in AMD care, surgical innovation, breakthroughs in imaging, and more.
Rebecca Hepp, Editor-in-Chief
November/December 2022 | Meeting Minutes
23rd Annual Advanced Vitreoretinal Techniques & Technology in Chicago
AVTT’s dynamic program was a big hit with everyone who attended this year. Get the recap here.
Alexis Warren, MD, and Daniel Wang, MD
November/December 2022 | Imaging
Defining Ocular Ischemic Processes: An Atlas
Advanced imaging can improve the identification of ocular manifestations of systemic conditions.
Robert Sergott, MD
November/December 2022 | Surgical Pearls
Managing a Giant Retinal Tear Without Vitrectomy
Laser retinopexy alone may be an option for select patients with macula-sparing GRTs.
Nhuong-Sao Ton, MS, and Murtaza Adam, MD
November/December 2022 | Global Perspectives
Pearls for Implanting a Carlevale IOL
A brief overview of the steps for a sutureless scleral-fixated IOL in the absence of capsular support.
Kai Januschowski, MD; Lukas Bisorca-Gassendorf, MD; Karl T. Boden, MD; and Annekatrin Rickmann, MD
November/December 2022 | Features
What’s in the Works for Wet AMD
Researchers are pushing forward with novel therapeutics and delivery approaches.
Meghana Kalavar, MD; Dante Pieramici MD; and Nika Bagheri, MD
November/December 2022 | Features
Recent Happenings in the Geographic Atrophy Space
Many new therapies are pushing their way through the pipeline.
Ruby Hollinger, BA; Viet Chau, MD; and Jayanth Sridhar, MD
November/December 2022 | Features
DR Research Roundup: Phase 2 and 3
A look at new ways to use trusted treatments and novel pathways to fight diabetic eye disease.
Lauren Kiryakoza, MD, and Jayanth Sridhar, MD
November/December 2022 | Features
Clinical Trials Targeting RVO
New therapeutics under investigation are showing promise for the treatment of retinal vein occlusion.
Jessica Lee, BS; Linnet Rodriguez, MD; Meera D. Sivalingam, MD; and Yoshihiro Yonekawa, MD
November/December 2022 | Features
Retinal Imaging Pipeline Updates
New tools are providing researchers ways to see the retina like never before.
Kara Rickford, MS, and Jay Chhablani, MD
November/December 2022 | Features
The Path to Product Launch
Experts share their four-step approach to product development and commercialization.
Steve Charles, MD, FACS, FICS, and Adam Pflugrath, MD
November/December 2022 | Ocular Oncology
Intraarterial Chemotherapy for Recurrent Retinoblastoma
An excellent option for primary and secondary therapy.
Rachel S. Kim, BS; Kushal U. Agrawal, MS; and Carol L. Shields, MD
November/December 2022 | Visually Speaking
Mizuo-Nakamura Phenomenon in X-linked Retinoschisis
This finding may be present in cases of XLRS in the absence of genetic variants for Oguchi disease.
Natasha Ferreira Santos da Cruz, MD; Ashley Lopez-Canizares, MS; and Audina M. Berrocal, MD
November/December 2022 | Medical Retina
A Toxic Side Effect of Dropless Surgery
Be careful of potentially toxic compounds found in some triamcinolone-moxifloxacin injections used in cataract surgery in place of postoperative drops.
Kishan G. Patel, MD, and Ashkan M. Abbey, MD
November/December 2022 | 5Q Interview
5Q with Jonathan F. Russell, MD, PhD
Jonathan F. Russell, MD, PhD